Personal information

Other IDs

Scopus Author ID: 16041417500
ResearcherID: A-9005-2017
Loop profile: 41493

Keywords

Immunology, Cancer, Cancer Stem cells

Countries

Italy

Activities

Collapse all

Employment (7)

Università degli Studi di Torino: Torino, IT

2022-12-23 to present | Associate Professor (Dept of Molecular Biotechnology and Health Science)
Employment
Source: Self-asserted source
Laura Conti

University of Turin: Turin, Piemonte, IT

2019-12-23 to 2022-12-22 | Assistant Professor (RTDb) (Dept of Molecular Biotechnology and Health Science)
Employment
Source: Self-asserted source
Laura Conti

University of Turin: Turin, Piemonte, IT

2018-01-01 to 2019-12-22 | Post-doc Fellow (Dept of Molecular Biotechnology and Health Science)
Employment
Source: Self-asserted source
Laura Conti

Fondazione Umberto Veronesi: Torino, IT

2016-01-01 to 2017-12-31 | Post-doc Fellow (Dept of Molecular Biotechnology and Health Science)
Employment
Source: Self-asserted source
Laura Conti

Fondazione Ricerca Molinette Onlus: Torino, Piemonte, IT

2015-05-01 to 2016-01-01 | Post-doc (Università degli Studi di Torino)
Employment
Source: Self-asserted source
Laura Conti

Fondazione Umberto Veronesi: Milano, Lombardia, IT

2014-05-01 to 2015-04-30 | Post-doc (Università degli tudi di Torino)
Employment
Source: Self-asserted source
Laura Conti

Bracco Imaging SPA: Colleretto Giacosa, Piemonte, IT

2007-11-11 to 2009-11-11 | Post-doc fellow
Employment
Source: Self-asserted source
Laura Conti

Education and qualifications (2)

Università degli Studi di Torino: Torino, Piemonte, IT

2003-10-01 to 2007-12-07 | PhD in Immunology and Cell Biology (Dept. of Clinical and Biological Sciences)
Education
Source: Self-asserted source
Laura Conti

Università degli Studi di Torino: Torino, Piemonte, IT

1998-10-01 to 2003-07-24 | Master in Medical Biotechnology
Education
Source: Self-asserted source
Laura Conti

Funding (4)

Pancreatic cancer therapy based on combination of DNA vaccination and PI3Kgamma inhibition

2016-01 to 2018-12 | Grant
Ministero della Salute (Rome, IT)
GRANT_NUMBER:

RF-2013-02354892
Source: Self-asserted source
Laura Conti

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine/glutamate antiporter

2016-01 to 2016-12 | Salary award
Fondazione Umberto Veronesi (Milano, IT)
Source: Self-asserted source
Laura Conti

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine/glutamate antiporter

2015-04 to 2015-10 | Salary award
Fondazione Carlo Chianello (Palermo, IT)
Source: Self-asserted source
Laura Conti

Identification of Cancer Stem Cell Oncoantigens For The Immune-Targeting Of Triple Negative Breast Cancer

2014-05 to 2015-04 | Salary award
Fondazione Umberto Veronesi (Milano, IT)
Source: Self-asserted source
Laura Conti

Works (50 of 65)

Items per page:
Page 1 of 2

Effect of Mitoquinone on sperm quality of cryopreserved stallion semen

Journal of Equine Veterinary Science
2024-10 | Journal article
DOI: 10.1016/j.jevs.2024.105168
Contributors: Ahmed R. Elkhawagah; Gian Guido Donato; Mariagrazia Poletto; Nicola A. Martino; Leila Vincenti; Laura Conti; Denis Necchi; Tiziana Nervo
Source: check_circle
Crossref

Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern

International Journal of Molecular Sciences
2024-10-26 | Journal article
DOI: 10.3390/ijms252111509
Contributors: Chiara Cossu; Valentina Franceschi; Antonino Di Lorenzo; Elisabetta Bolli; Sergio Minesso; Camilla Cotti; Laura Conti; Gaetano Donofrio
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes

Angewandte Chemie International Edition
2024-02-05 | Journal article
DOI: 10.1002/anie.202313485
Contributors: Enza Di Gregorio; Chiara Papi; Laura Conti; Antonino Di Lorenzo; Eleonora Cavallari; Marco Salvatore; Carlo Cavaliere; Giuseppe Ferrauto; Silvio Aime
Source: check_circle
Crossref

A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes

Angewandte Chemie
2024-02-05 | Journal article
DOI: 10.1002/ange.202313485
Contributors: Enza Di Gregorio; Chiara Papi; Laura Conti; Antonino Di Lorenzo; Eleonora Cavallari; Marco Salvatore; Carlo Cavaliere; Giuseppe Ferrauto; Silvio Aime
Source: check_circle
Crossref

The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?

International Journal of Molecular Sciences
2023-12-29 | Journal article
DOI: 10.3390/ijms25010456
Contributors: Chiara Cossu; Antonino Di Lorenzo; Irene Fiorilla; Alberto Maria Todesco; Valentina Audrito; Laura Conti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550513
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Data from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.c.6550513.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S1 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544044
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S1 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544044.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S2 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544041
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S2 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544041.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S3 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544038
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S3 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544038.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S4 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544035
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S4 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544035.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S5 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544032
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S5 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544032.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S6 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544029
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S6 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544029.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S7 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544026
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Figure S7 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544026.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Supplementary Methods from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544023
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Supplementary Methods from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

2023-04-04 | Preprint
DOI: 10.1158/2326-6066.22544023.v1
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513151
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513151.v1
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22428811.v1
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22428814.v1
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22428814
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22428811
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment

Cancers
2022-12-20 | Journal article
DOI: 10.3390/cancers15010008
Contributors: Enza Di Gregorio; Chiara Romiti; Antonino Di Lorenzo; Federica Cavallo; Giuseppe Ferrauto; Laura Conti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models

Biomedicines
2022-11-08 | Journal article
DOI: 10.3390/biomedicines10112843
Contributors: Giuseppina Barutello; Antonino Di Lorenzo; Alessandro Gasparetto; Chiara Galiazzi; Elisabetta Bolli; Laura Conti; Federica Cavallo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation

International Journal of Molecular Sciences
2022-10-25 | Journal article
DOI: 10.3390/ijms232112878
Contributors: Martina Capozza; Rachele Stefania; Valentina Dinatale; Valeria Bitonto; Laura Conti; Cristina Grange; Renata Skovronova; Enzo Terreno
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer

Cancers
2022-08-22 | Journal article
DOI: 10.3390/cancers14164054
Contributors: Junbiao Wang; Alessia Lamolinara; Laura Conti; Mara Giangrossi; Lishan Cui; Maria Beatrice Morelli; Consuelo Amantini; Maurizio Falconi; Caterina Bartolacci; Cristina Andreani et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial

Journal for ImmunoTherapy of Cancer
2022-05 | Journal article
DOI: 10.1136/jitc-2021-004007
Contributors: Federica Riccardo; Lidia Tarone; Mariateresa Camerino; Davide Giacobino; Selina Iussich; Giuseppina Barutello; Maddalena Arigoni; Laura Conti; Elisabetta Bolli; Elena Quaglino et al.
Source: check_circle
Crossref

Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

Cancer Research
2021-09-15 | Journal article
DOI: 10.1158/0008-5472.CAN-20-3150
Contributors: Laura Seclì; Lidia Avalle; Pietro Poggio; Giuseppe Fragale; Cristiana Cannata; Laura Conti; Andrea Iannucci; Giovanna Carrà; Cristina Rubinetto; Barbara Miniscalco et al.
Source: check_circle
Crossref

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer

Cancers
2021-02-20 | Journal article
DOI: 10.3390/cancers13040894
Contributors: Roberto Ruiu; Giuseppina Barutello; Maddalena Arigoni; Federica Riccardo; Laura Conti; Giulia Peppino; Laura Annaratone; Caterina Marchiò; Giulio Mengozzi; Raffaele Adolfo Calogero et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies

Cells
2021-01-08 | Journal article
DOI: 10.3390/cells10010108
Contributors: Jolanda Magri; Alessandro Gasparetto; Laura Conti; Enzo Calautti; Chiara Cossu; Roberto Ruiu; Giuseppina Barutello; Federica Cavallo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential

British Journal of Cancer
2021-01-05 | Journal article
DOI: 10.1038/s41416-020-01173-0
Contributors: Annasofia Anemone; Lorena Consolino; Laura Conti; Pietro Irrera; Myriam Y. Hsu; Daisy Villano; Walter Dastrù; Paolo E. Porporato; Federica Cavallo; Dario Livio Longo
Source: check_circle
Crossref

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota

International Journal of Molecular Sciences
2020-12-10 | Journal article
DOI: 10.3390/ijms21249418
Contributors: Antonino Di Lorenzo; Elisabetta Bolli; Lidia Tarone; Federica Cavallo; Laura Conti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

Cancer Immunology Research
2020-08-01 | Journal article
DOI: 10.1158/2326-6066.CIR-20-0082
Contributors: Laura Conti; Elisabetta Bolli; Antonino Di Lorenzo; Valentina Franceschi; Francesca Macchi; Federica Riccardo; Roberto Ruiu; Luca Russo; Elena Quaglino; Gaetano Donofrio et al.
Source: check_circle
Crossref

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer

Cancers
2020-06-08 | Journal article
DOI: 10.3390/cancers12061492
Contributors: Valeria Rolih; Jerri Caldeira; Elisabetta Bolli; Ahmad Salameh; Laura Conti; Giuseppina Barutello; Federica Riccardo; Jolanda Magri; Alessia Lamolinara; Karla Parra et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

Vaccines
2020-04-06 | Journal article
DOI: 10.3390/vaccines8020166
Contributors: Federica Riccardo; Giuseppina Barutello; Angela Petito; Lidia Tarone; Laura Conti; Maddalena Arigoni; Chiara Musiu; Stefania Izzo; Marco Volante; Dario Livio Longo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice

Scientific Reports
2020-01-21 | Journal article
DOI: 10.1038/s41598-020-57820-2
Contributors: Elvira Smeralda Famulari; Victor Navarro-Tableros; Maria Beatriz Herrera Sanchez; Giulia Bortolussi; Marta Gai; Laura Conti; Lorenzo Silengo; Emanuela Tolosano; Ciro Tetta; Andrés Fernando Muro et al.
Source: check_circle
Crossref

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells

OncoImmunology
2018-12-02 | Journal article
DOI: 10.1080/2162402X.2018.1494108
Contributors: Gaetano Donofrio; Giulia Tebaldi; Stefania Lanzardo; Roberto Ruiu; Elisabetta Bolli; Andrea Ballatore; Valeria Rolih; Francesca Macchi; Laura Conti; Federica Cavallo
Source: check_circle
Crossref

Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells

Nanoscale
2015 | Journal article
DOI: 10.1039/c5nr00352k
EID:

2-s2.0-84926482994
Contributors: Geninatti Crich, S.; Cadenazzi, M.; Lanzardo, S.; Conti, L.; Ruiu, R.; Alberti, D.; Cavallo, F.; Cutrin, J.C.; Aime, S.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier

Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells

Oncotarget
2015 | Journal article
EID:

2-s2.0-84929611036
Contributors: Principe, M.; Ceruti, P.; Shih, N.-Y.; Chattaragada, M.S.; Rolla, S.; Conti, L.; Bestagno, M.; Zentilin, L.; Yang, S.-H.; Migliorini, P. et al.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier

A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells

PLoS ONE
2014 | Journal article
DOI: 10.1371/journal.pone.0106193
EID:

2-s2.0-84906972436
Contributors: Fornari, C.; Beccuti, M.; Lanzardo, S.; Conti, L.; Balbo, G.; Cavallo, F.; Calogero, R.A.; Cordero, F.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier

B7h triggering inhibits the migration of tumor cell lines

Journal of Immunology
2014 | Journal article
DOI: 10.4049/jimmunol.1300587
EID:

2-s2.0-84901251138
Contributors: Dianzani, C.; Minelli, R.; Gigliotti, C.L.; Occhipinti, S.; Giovarelli, M.; Conti, L.; Boggio, E.; Shivakumar, Y.; Baldanzi, G.; Malacarne, V. et al.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier

Microenvironment, oncoantigens, and antitumor vaccination: Lessons learned from BALB-neuT mice

BioMed Research International
2014 | Journal article
DOI: 10.1155/2014/534969
EID:

2-s2.0-84903641503
Contributors: Conti, L.; Ruiu, R.; Barutello, G.; Macagno, M.; Bandini, S.; Cavallo, F.; Lanzardo, S.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice

Journal of Immunology
2014 | Journal article
DOI: 10.4049/jimmunol.1301248
EID:

2-s2.0-84901251487
Contributors: Macagno, M.; Bandini, S.; Stramucci, L.; Quaglino, E.; Conti, L.; Balmas, E.; Smyth, M.J.; Lollini, P.-L.; Musiani, P.; Forni, G. et al.
Source: Self-asserted source
Laura Conti via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (2 reviews for 2 publications/grants)

Review activity for Nature communications (1)
Review activity for NPJ breast cancer. (1)
How many people are using ORCID?